A new scientific review highlights the potential of CBD to treat and manage the symptoms of conditions like epilepsy, pain, cancer, schizophrenia, diabetes and COVID-19, among others.
The wide-ranging 11-page review takes up the broad task of trying “to summarize comprehensively the impact of cannabis on human health,” finding that while the field has yet to be thoroughly explored, the plant and its components exhibit “neuroprotective, anti-inflammatory, anti-thrombotic, anti-bacterial, analgesic, and antiepileptic properties.”
The study, “Beneficial effects of cannabidiol from Cannabis,” was published last month in the journal Applied Biological Chemistry. In addition to the overview of cannabis on human health, it “delves into recent CBD research advancements, highlighting the compound’s potential medical applications.”
“Our exploration encompasses its pharmacological properties, mechanisms of action, and the accumulating evidence supporting its use in various medical conditions,” authors wrote. “Additionally, we critically assess challenges and controversies surrounding CBD research, including regulatory considerations and potential adverse effects.”
It features sections on cannabinoids as treatment for the form of epilepsy known as Dravet syndrome, as a promising pain relief alternative, as a way to manage the symptoms of schizophrenia and even as a possible inhibitor of COVID-19 infection. It also touches on “the diverse anticancer properties of cannabinoids” that authors said present “promising opportunities for future therapeutic interventions in cancer treatment,” as well as CBD’s apparent effects on diabetes-related biological processes.
To read more, click on Marijuana Moment